Launched by a BioEntrepreneur-In-Residence at the New York State Center for Biotechnology, Traverse Biosciences was established in June 2013 to commercialize promising biomedical technologies available for license from Stony Brook University.
Traverse Biosciences was named to reflect our core mission to successfully navigate the "valley of death" separating an early-stage academic technology from a viable commercial product for the benefit of health, society and the economy. Our business model is centered around the achievement of key technical milestones in alignment with a validated market opportunity and a clear exit strategy. With the support of our investors and stakeholders, our goal is to strategically mitigate product development risks and add tangible commercial value to our assets.
Please check back soon for additional information!